Stock Analysis

We Take A Look At Whether argenx SE's (EBR:ARGX) CEO May Be Underpaid

Advertisement

Key Insights

  • argenx's Annual General Meeting to take place on 27th of May
  • CEO Tim Van Hauwermeiren's total compensation includes salary of US$757.7k
  • The total compensation is 39% less than the average for the industry
  • argenx's total shareholder return over the past three years was 75% while its EPS grew by 98% over the past three years

The impressive results at argenx SE (EBR:ARGX) recently will be great news for shareholders. This would be kept in mind at the upcoming AGM on 27th of May which will be a chance for them to hear the board review the financial results, discuss future company strategy and vote on resolutions such as executive remuneration and other matters. Here we will show why we think CEO compensation is appropriate and discuss the case for a pay rise.

View our latest analysis for argenx

Comparing argenx SE's CEO Compensation With The Industry

Our data indicates that argenx SE has a market capitalization of €31b, and total annual CEO compensation was reported as US$7.8m for the year to December 2024. Notably, that's a decrease of 35% over the year before. While this analysis focuses on total compensation, it's worth acknowledging that the salary portion is lower, valued at US$758k.

On comparing similar companies in the Belgium Biotechs industry with market capitalizations above €7.1b, we found that the median total CEO compensation was US$13m. Accordingly, argenx pays its CEO under the industry median. What's more, Tim Van Hauwermeiren holds €27m worth of shares in the company in their own name, indicating that they have a lot of skin in the game.

Component20242023Proportion (2024)
SalaryUS$758kUS$656k10%
OtherUS$7.1mUS$11m90%
Total CompensationUS$7.8m US$12m100%

Speaking on an industry level, nearly 59% of total compensation represents salary, while the remainder of 41% is other remuneration. It's interesting to note that argenx allocates a smaller portion of compensation to salary in comparison to the broader industry. It's important to note that a slant towards non-salary compensation suggests that total pay is tied to the company's performance.

ceo-compensation
ENXTBR:ARGX CEO Compensation May 21st 2025

A Look at argenx SE's Growth Numbers

argenx SE has seen its earnings per share (EPS) increase by 98% a year over the past three years. It achieved revenue growth of 82% over the last year.

Overall this is a positive result for shareholders, showing that the company has improved in recent years. It's great to see that revenue growth is strong, too. These metrics suggest the business is growing strongly. Moving away from current form for a second, it could be important to check this free visual depiction of what analysts expect for the future.

Has argenx SE Been A Good Investment?

Most shareholders would probably be pleased with argenx SE for providing a total return of 75% over three years. As a result, some may believe the CEO should be paid more than is normal for companies of similar size.

In Summary...

Seeing that company performance has been quite good recently, some shareholders may feel that CEO compensation may not be the biggest focus in the upcoming AGM. However, despite the strong growth in earnings and share price growth, the focus for shareholders would be how the company plans to steer the company towards sustainable profitability in the near future.

Shareholders may want to check for free if argenx insiders are buying or selling shares.

Switching gears from argenx, if you're hunting for a pristine balance sheet and premium returns, this free list of high return, low debt companies is a great place to look.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ENXTBR:ARGX

argenx

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Exceptional growth potential with excellent balance sheet.

Advertisement

Updated Narratives

CE
CEG logo
cementafriend on Constellation Energy ·

Constellation Energy Dividends and Growth

Fair Value:US$348.054.7% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KH
CRWV logo
Khagani on CoreWeave ·

CoreWeave's Revenue Expected to Rocket 77.88% in 5-Year Forecast

Fair Value:US$11033.5% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PO
BIS logo
PortfolioPlus on Bisalloy Steel Group ·

Bisalloy Steel Group will shine with a projected profit margin increase of 12.8%

Fair Value:AU$6.7118.0% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
108 users have followed this narrative
10 users have commented on this narrative
21 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3929.3% undervalued
936 users have followed this narrative
6 users have commented on this narrative
24 users have liked this narrative
OS
oscargarcia
GOOGL logo
oscargarcia on Alphabet ·

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.

Fair Value:US$3405.8% undervalued
144 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative